Tuesday, October 9, 2018

Neurovascular Devices/Interventional Neurology - Vital Factors of the Global Industry Growth

[193 Pages Report] The global interventional neurology/neurovascular devices market is estimated to reach USD 2.62 Billion by 2021, at a CAGR of 8.6% during the forecast period. 

The large patient population base with target diseases, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and growing market demand for effective neurovascular devices are some key factors driving the growth of the market.


Key Market Restraints:
# Stringent Regulations
# Dearth of Skilled Neurosurgeons



Key Market Opportunities:
# Increasing Research Activities in the Field of Neurovascular Therapies
# Rising Demand for Minimally Invasive Neurosurgical Procedures



Ongoing Clinical Studies:
# Embolization Coiling Procedures
# Carotid Artery Stenting Procedures
# Embolic Protection Procedures
# Flow Diversion Procedures
# Supporting Techniques
# Neurothrombectomy Procedures


Download the PDF Brochure for More Details@ http://bit.ly/2OiLeqf

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific is the fastest-growing geographic segment in the neurovascular devices/interventional neurology market. The large market growth of this geographic segment can be attributed to the presence of a large patient population base for target diseases, rising awareness among neurosurgeons related to the benefits offered by interventional neurology devices, and ongoing government initiatives to modernize & expand healthcare infrastructure.
Product Launches and Enhancements is the Key Strategy Adopted by Leading Market Players to Foster their Growth in the Global Neurovascular Devices/Interventional Neurology Market

The key players in the neurovascular devices/interventional neurology market focused on various strategies such as product launches & enhancements; agreements and collaborations; strategic acquisitions; and expansions to increase market shares in the global market. Product launches & enhancements were the key strategies adopted by major industry players to achieve the desired market growth during 2013-2016. 

This strategy was mainly adopted by Stryker Corporation (U.S.), Medtronic plc (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), and MicroPort Scientific Corporation (China). Apart from product launches & enhancements, many prominent players also adopted agreements & collaborations as the key growth strategy to strengthen market presence, enhance R&D capabilities, and to expand distribution networks to generate additional demand by sensitizing end users through an increase in availability of neurovascular products.

Target Audience
  • Healthcare service providers (Hospitals and surgical centers)
  • Non-government organizations
  • Government regulatory authorities
  • Research laboratories and academic institutes
  • Clinical research organizations (CROs)
  • Research and development companies
  • Market research and consulting firms

No comments:

Post a Comment